Monogram Technologies (Monogram Technologies) Beneish M-Score : 0.00 (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Monogram Technologies Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Monogram Technologies's Beneish M-Score or its related term are showing as below:

During the past 7 years, the highest Beneish M-Score of Monogram Technologies was 0.00. The lowest was 0.00. And the median was 0.00.

Monogram Technologies Beneish M-Score Historical Data

The historical data trend for Monogram Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Technologies Beneish M-Score Chart

Monogram Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

Monogram Technologies Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beneish M-Score	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Monogram Technologies's Beneish M-Score

For the Medical Devices subindustry, Monogram Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monogram Technologies's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monogram Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Monogram Technologies's Beneish M-Score falls into.

Monogram Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Monogram Technologies for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Mar24) TTM:

Last Year (Mar23) TTM:

Total Receivables was $0.00 Mil.
Revenue was 0 + 0.365 + 0 + 0 = $0.37 Mil.
Gross Profit was 0 + 0.365 + 0 + 0 = $0.37 Mil.
Total Current Assets was $10.71 Mil.
Total Assets was $12.54 Mil.
Property, Plant and Equipment(Net PPE) was $1.34 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.42 Mil.
Selling, General, & Admin. Expense(SGA) was $6.12 Mil.
Total Current Liabilities was $1.98 Mil.
Long-Term Debt & Capital Lease Obligation was $0.33 Mil.
Net Income was -3.507 + -3.654 + -0.996 + -5.237 = $-13.39 Mil.
Non Operating Income was 0 + 0 + 2.646 + 0.44 = $3.09 Mil.
Cash Flow from Operations was -3.651 + -3.112 + -1.662 + -5.886 = $-14.31 Mil.

Total Receivables was $0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Current Assets was $8.27 Mil.
Total Assets was $10.59 Mil.
Property, Plant and Equipment(Net PPE) was $1.61 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.39 Mil.
Selling, General, & Admin. Expense(SGA) was $4.38 Mil.
Total Current Liabilities was $9.32 Mil.
Long-Term Debt & Capital Lease Obligation was $0.46 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0 / 0.365)	/	(0.002 / 0)
	=	0	/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0 / 0)	/	(0.365 / 0.365)
	=		/	1
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (10.707 + 1.338) / 12.542)	/	(1 - (8.274 + 1.608) / 10.589)
	=	0.039627	/	0.066767
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0.365	/	0
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.394 / (0.394 + 1.608))	/	(0.416 / (0.416 + 1.338))
	=	0.196803	/	0.237172
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(6.12 / 0.365)	/	(4.379 / 0)
	=	16.767123	/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.331 + 1.984) / 12.542)	/	((0.462 + 9.321) / 10.589)
	=	0.18458	/	0.923883
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-13.394 - 3.086	-	-14.311)	/	12.542
	=	-0.172939

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Monogram Technologies Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Monogram Technologies's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Monogram Technologies (Monogram Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Technologies Inc (NAS:MGRM) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

J7J:Germany

Address

3913 Todd Lane, Suite 307, Austin, TX, USA, 78744

Website

https://www.monogramorthopedics.com

Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Executives

Paul H Riss	director
Noel Knape	officer: Chief Financial Officer	3913 TODD LANE, AUSTIN TX 78744
Benjamin Sexson	director, 10 percent owner, officer: Chief Executive Officer	3913 TODD LANE, AUSTIN TX 78744
Noel Goddard	director	3913 TODD LANE, AUSTIN TX 78744
Kamran Shamaei	officer: Chief Technology Officer	3913 TODD LANE, AUSTIN TX 78744
Douglas Unis	director	3913 TODD LANE, AUSTIN TX 78744